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To assess risk for cattle-to-human transmission of pri-
ons that cause uncommon forms of bovine spongiform en-
cephalopathy (BSE), we inoculated mice expressing human 
PrP Met129 with ﬁ  eld isolates. Unlike classical BSE agent, 
L-type prions appeared to propagate in these mice with no 
obvious transmission barrier. H-type prions failed to infect 
the mice.
T
he epizootic of bovine spongiform encephalopathy 
(BSE) is under control in European countries >20 
years after the ﬁ  rst cases were diagnosed in the United 
Kingdom. Thus far, BSE is the only animal prion disease 
known to have been transmitted to humans, leading to a 
variant form of Creutzfeldt-Jakob disease (vCJD) (1). 
The large-scale testing of livestock nervous tissues for 
the presence of protease-resistant prion protein (PrPres) 
has enabled assessment of BSE prevalence and exclu-
sion of BSE-infected animals from human food (2). This 
active surveillance has led to the recognition of 2 variant 
PrPres molecular signatures, termed H-type and L-type 
BSE. They differ from that of classical BSE by having 
protease-resistant fragments of a higher (H) or a slightly 
lower (L) molecular mass, respectively, and different 
patterns of glycosylation (3–5). Both types have been 
detected worldwide as rare cases in older animals, at a 
low prevalence consistent with the possibility of spo-
radic forms of prion diseases in cattle (6). Their experi-
mental transmission to mice transgenic for bovine PrP 
demonstrated the infectious nature of such cases and the 
existence of distinct prion strains in cattle (5,7–9).
Like the classical BSE agent, H- and L-type prions 
can propagate in heterologous species (7–11). Thus, 
both agents are transmissible to transgenic mice express-
ing ovine PrP (VRQ allele). Although H-type molecular 
properties are conserved on these mice (9), L-type pri-
ons acquire molecular and neuropathologic phenotypic 
traits undistinguishable from BSE or BSE-related agents 
that have followed the same transmission history (7). 
Similar ﬁ  ndings have been reported in wild-type mice 
(8). An understanding of the transmission properties of 
these newly recognized prions when confronted with 
the human PrP sequence is needed. In a previous study, 
we measured kinetics of PrPres deposition in the brain to 
show that L-type prions replicate faster than BSE prions 
in experimentally inoculated mice that express human 
PrP (7). In a similar mouse model, the L-type agent (al-
ternatively named BASE) was also shown to produce 
overt disease with an attack rate of ≈30% (12). However, 
no strict comparison with BSE agent has been attempt-
ed. As regards the H-type agent, its potential virulence 
for mice that express human PrP Met129 remains to be 
assessed. We now report comparative transmission data 
for these atypical and classical BSE prions.
The Study
The bovine isolates used in this study have been 
previously described; they all exhibited high infectivity 
levels in bovine PrP mice (4,7,9). The equivalent of 2 
mg of infected bovine brain tissue was injected intrac-
erebrally into tg650 mice. This line of mice overex-
presses (≈6-fold) human PrP with methionine at codon 
129 (Met129) on a Zurich mouse PrP null background and 
has been shown to be fully susceptible to vCJD agent 
(13). The resulting transmission data available to date 
are summarized in the Table. The primary transmission 
of classical BSE isolates was inefﬁ  cient as judged by the 
absence of clear neurologic signs and by Western blot 
detection of PrPres in the brain of only 4/25 inoculated 
mice. The PrPres banding pattern was essentially similar 
to that of vCJD (low molecular mass fragments and pre-
dominance of diglycoform species; Figure 1).
Secondary passages were performed by using PrPres-
negative or PrPres-positive individual mouse brains. Ev-
ery time brain homogenate from an aged mouse (>630 
days of age) was inoculated, transmission was observed 
in >80% of the mice, as determined by clinical signs and 
PrPres accumulation. The mean survival time was ≈600 
days (Table; additional data not shown). By the third 
passage, mean survival time approached ≈500 days, as 
is usually observed with vCJD cases (Table; 13). The 
vCJD-like PrPres proﬁ  le was conserved in all 50 positive 
brains analyzed (Figure 1). Transmission of L-type iso-
lates to tg650 mice produced markedly different results. 
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First, the 4 L-type isolates induced neurologic disease in 
almost all mice; survival times averaged 600–700 days 
(Table). Second, PrPres accumulated in the brain of all 33 
mice analyzed. The molecular proﬁ  le was distinct from 
BSE or vCJD; prominent monoglycosylated PrPres spe-
cies resembled those found in cattle (Figure 1). Third, 
we found neither shortening of the survival time on 
subpassage (1 isolate tested, 2 brains) (Table; data not 
shown) nor change in PrPres proﬁ  le (Figure 1).
In sharp contrast, BSE H-type isolates failed to 
transmit disease to or even infect tg650 mice. None of 
the inoculated mice had a detectable level of PrPres in 
the brain (22 analyzed). Secondary passages were per-
formed with brains of mice that died at various time 
points. All inoculated mice survived, and none showed a 
PrPres signal in the brain (15 mice analyzed).
To further compare the behavior of the 3 bovine pri-
ons in tg650 mice, we examined the regional distribution 
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Table. Transmission of classical and atypical BSE isolates to transgenic mice expressing human prion protein (Met
129)* 
1st passage  2nd passage  3rd passage 
Isolate
Origin 
(identification no.) 
Total 
affected†
Mean survival 
time‡
Total 
affected†
Mean survival 
time‡
Total 
affected†
Mean survival 
time‡
BSE France (3) 1/6§ 872 6/7 568 ± 65  8/8 523 ± 22 
France (3)  2/6 627, 842
Germany¶  1/4§ 802 6/6 677 ± 54  8/8 555 ± 24 
Italy (128204)  0/5 606–775
Belgium 0/4 696–829
L-type  Italy (1088)  9/9 607 ± 23  11/11 653 ± 13  NA
France (7)  7/7 574 ± 35  0/8# >450
France (10)  8/8 703 ± 19 
France (11)  9/9 647 ± 26 
H-type France  (1)  0/6 376–721 0/7 350–850 NA
France (2) 0/6 313–626 0/8 302–755 NA
France (5) 0/10 355–838 NA
*BSE, bovine spongiform encephalopathy; NA, not available (experiments still ongoing). 
†Mice with neurologic signs and positive for protease-resistant prion protein by Western blotting. 
‡Days ± SE of the mean. For mice with negative results, only the range of survival time is given. 
§First passage performed on hemizygous mice. Note that the primary transmission of France (3) isolate was performed on both hemizygous and 
homozygous mice. 
¶One passage on transgenic mice expressing bovine prion protein (7).
#Ongoing experiment. 
Figure 1.  Protease-resistant prion protein (PrPres) in 
the brains of human PrP transgenic mice infected with 
atypical or zoonotic bovine spongiform encephalopathy 
(BSE) agents. A) Representative Western blot analysis 
of PrPres extracted (for detailed protocol, see 7) from 
brain homogenates of mice at terminal stage of disease 
or at end of lifespan after serial transmission of atypical 
(L-type and H-type) or classical BSE isolates. The 
amount of equivalent brain tissue loaded onto the gels 
was 0.01 mg (BSE; Fr3 isolate, 2nd and 3rd passage), 
0.3 mg (L-type and 1st passage of BSE), and 10 
mg (PrPres-negative samples). Anti-PrP monoclonal 
antibody Sha31 was used for PrPres detection. Immuno-
reactivity was determined by chemiluminescence. B) 
Ratio of diglycosylated and monoglycosylated PrPres 
species in the brains of mice after serial transmission 
of L-type or BSE isolates (data plotted as means ± 
standard error of the mean). Primary passage of L-type 
isolates are represented as triangles (orange, It; blue, 
Fr7; green, Fr10; pink, Fr11) and BSE as squares (light 
blue, Fr3; red, Ge). Passages are indicated by unﬁ  lled 
symbols of the same color (solid line, second passage; 
broken line, third passage). The ratio was determined 
after acquisition of PrPres chemiluminescent signals 
with a digital imager as previously described (7). Note 
the distinct glycoform ratio between L-type and BSE 
groups. It, Italy; Fr, France; Ge, Germany.and intensity of PrPres deposition in the brain (14). His-
toblot analyses (3 brains per infection) were performed 
on primary (L-type, H-type) and secondary passages (L-
type, H-type, BSE). As shown in Figure 2, L-type and 
BSE agents showed clear differences according to both 
the aspect and localization of the PrP deposits. Granu-
lar PrP deposits were scattered throughout the brain 
with BSE, as has been previously observed with vCJD 
(13). The ventral nuclei of the thalamus, cerebral cortex, 
oriens layer of the hippocampus, and raphe and tegmen-
tum nuclei of the brain stem were strongly stained. With 
BSE-L, the staining was ﬁ  ner and essentially conﬁ  ned to 
the habenular, geniculate, and dorsal nuclei of the thala-
mus; the lateral hypothalamus; the lacunosom molecu-
lare layer of the hippocampus; the superﬁ  cial gray layer 
of the superior colliculus; and the raphe nuclei of the 
brain stem. Finally, PrPres could not be detected on brain 
sections from mice inoculated with H-type isolates (data 
not shown), thus conﬁ  rming the Western blot data.
Conclusions
We found that atypical L-type bovine prions can 
propagate in human PrP transgenic mice with no signiﬁ  -
cant transmission barrier. Lack of a barrier is supported 
by the 100% attack rate, the absence of reduction of 
incubation time on secondary passage, and the conser-
vation of PrPres electrophoretic proﬁ  le. In comparison, 
transmission of classical BSE agent to the same mice 
showed a substantial barrier. Indeed, 3 passages were 
necessary to reach a degree of virulence comparable to 
that of vCJD agent in these mice (13), which likely re-
ﬂ  ects progressive adaptation of the agent to its new host. 
At variance with the successful transmission of classi-
cal BSE and L-type agents, H-type agent failed to in-
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Figure 2. Representative histoblots in 4 different anteroposterior sections showing the distribution of disease-speciﬁ  c PrPres deposits in the 
brains of tg650 mice infected with bovine spongiform encephalopathy (BSE) or L-type BSE. Panels A–D show infection with BSE (second 
passage of France 3). Panels E–H show infection with L-type BSE (ﬁ  rst passage of France 7). Panels I–L show  infection with L-type 
BSE (second passage of Italy). Panels M–P show brain sections of an age-matched, mock-infected mouse, euthanized while healthy at 
700 days postinfection, for comparison. Note the differing aspect and distribution of PrPres deposits between brain of mice infected with 
BSE and BSE-L (arrowheads). Assignment of the positive brain regions has been made according to a mouse brain atlas after digital 
acquisition.Transmission of Atypical Bovine Prions to Mice
fect tg650 mice. These mice overexpress human PrP and 
were inoculated intracranially with a low dilution inocu-
lum (10% homogenate). Therefore, this result supports 
the view that the transmission barrier of BSE-H from 
cattle to humans might be quite robust. It also illustrates 
the primacy of the strain over PrP sequence matching for 
cross-species transmission of prions (15).
Extrapolation of our data raises the theoretical pos-
sibility that the zoonotic risk associated with BSE-L pri-
ons might be higher than that associated with classical 
BSE, at least for humans carrying the Met129 PrP allele. 
This information underlines the need for more intensive 
investigations, in particular regarding the tissue tropism 
of this agent. Its ability to colonize lymphoid tissues is a 
potential, key factor for a successful transmission by pe-
ripheral route. This issue is currently being explored in 
the tg650 mice. Although recent data in humanized mice 
suggested that BSE-L agent is likely to be lymphotropic 
(12), preliminary observations in our model suggested 
that its ability to colonize such tissues is comparatively 
much lower than that of classical BSE agent.
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